Skip to content

Clinical Performance Comparison of Two Contact Lenses

Clinical Evaluation of Two Silicone Hydrogel Frequent Replacement Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00975585
Enrollment
379
Registered
2009-09-11
Start date
2009-08-01
Completion date
2009-10-01
Last updated
2018-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The purpose of this study is to compare the clinical performance of two contact lenses.

Interventions

DEVICEsenofilcon A

soft contact lens, 2-week replacement indicated

soft contact lens with a 4-week replacement indicated.

Sponsors

Visioncare Research Ltd.
CollaboratorOTHER
Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Existing daily soft lens wearer. * Require a distance visual correction in both eyes. * Have a contact lens spherical distance refraction between -1.00D and -6.00D. * Have refractive astigmatism less than or equal to 1.00D in both eyes. * Achieve 20/30 or better corrected distance acuity. * Have normal eyes with no evidence of abnormality or disease.

Exclusion criteria

* Requires presbyopic correction. * Requires ocular medications. * Grade 3 or 4 ocular abnormalities. * Grade 3 corneal staining in more than one region. * Has had refractive surgery. * Any other injury or ocular surgery within 8 weeks prior to study enrollment. * Has abnormal lacrimal secretions. * Pre-existing ocular irritation that would preclude contact lens fitting. * Has keratoconus or other corneal irregularity. * Polymethyl methacrylate (PMMA), Hybrid or Rigid Gas Permeable (RGP) wear in the previous 8 weeks. * Wears habitual contact lenses that are toric, multifocal or worn extended wear. * Any systemic illness which would contraindicate lens wear or the medical treatment of would affect vision or successful lens wear. * Diabetic. * Infectious or immunosuppressive disease. * History of chronic eye disease (e.g glaucoma or age related macular degeneration). * Pregnancy, lactation or planning pregnancy at time of enrollment. * Participation in any concurrent clinical trial or in another trial in the last 30 days.

Design outcomes

Primary

MeasureTime frameDescription
Average Corneal Staining2 weeksThe overall score is the average of the total scores of each of five regions of the cornea. The minimum average score is 0 and the maximum average score is 3. Corneal surface abnormality as indicated by the severity of staining over five regions of the cornea (central, superior, inferior, nasal and temporal) was assessed by the investigator using the following scale: 0=none, 1=slight, 2=moderate, 3=severe.
Visual Acuity2 weeksVisual acuity was assessed by the investigator using the Snellen chart and converted to the logarithm of the minimum angle of resolution (logMAR). logMAR ideal is 0.0 and represents 20/20 Snellen visual acuity. logMAR values \> 0.00 indicate vision poorer than the ideal and values \<0.00 indicate vision greater than the ideal.
Overall Comfort2 weeksAfter two weeks of wear, subjects responded to a phone survey question regarding overall comfort of the study contact lenses (senofilcon A and lotrafilcon B) using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.

Secondary

MeasureTime frameDescription
Limbal Redness2 weeksThe investigator assessed limbal redness using the following scale: 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe
Bulbar Redness2 weeksThe investigator assessed bulbar redness using the following scale: 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe
Symptoms of Dryness2 weeksSubjects responded to a phone survey question regarding the frequency of the sensation of dryness while wearing the study contact lenses using the following scale: 1=Extreme, 2=Moderate, 3=Slight, 4=None

Countries

United States

Participant flow

Participants by arm

ArmCount
Senofilcon A
contact lens
184
Lotrafilcon B
contact lens
195
Total379

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event04
Overall StudyLens issue22
Overall StudyLost to Follow-up35
Overall StudyWithdrawal by Subject21

Baseline characteristics

CharacteristicSenofilcon ALotrafilcon BTotal
Age, Continuous29.7 years
STANDARD_DEVIATION 7
29.3 years
STANDARD_DEVIATION 6.9
29.5 years
STANDARD_DEVIATION 6.9
Region of Enrollment
United States
184 participants195 participants379 participants
Sex: Female, Male
Female
125 Participants136 Participants261 Participants
Sex: Female, Male
Male
59 Participants59 Participants118 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1840 / 195
serious
Total, serious adverse events
0 / 1840 / 195

Outcome results

Primary

Average Corneal Staining

The overall score is the average of the total scores of each of five regions of the cornea. The minimum average score is 0 and the maximum average score is 3. Corneal surface abnormality as indicated by the severity of staining over five regions of the cornea (central, superior, inferior, nasal and temporal) was assessed by the investigator using the following scale: 0=none, 1=slight, 2=moderate, 3=severe.

Time frame: 2 weeks

Population: Analysis included all subjects that completed the study.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Senofilcon AAverage Corneal Staining0.157 units on a scaleStandard Error 0.018
Lotrafilcon BAverage Corneal Staining0.170 units on a scaleStandard Error 0.018
Comparison: The alternative hypothesis is that senofilcon A contact lenses have non-inferior (less than or equal to) average corneal staining than lotrafilcon B after two weeks of wear.97.46% CI: [-0.058, 0.031]Mixed Models Analysis
Primary

Overall Comfort

After two weeks of wear, subjects responded to a phone survey question regarding overall comfort of the study contact lenses (senofilcon A and lotrafilcon B) using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.

Time frame: 2 weeks

Population: Analysis includes subjects that completed the study.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Senofilcon AOverall Comfort3.938 units on a scaleStandard Error 0.09
Lotrafilcon BOverall Comfort3.536 units on a scaleStandard Error 0.091
Comparison: The alternative hypothesis is that senofilcon A contact lenses have a higher rating of overall comfort than lotrafilcon B after two weeks of wear.97.46% CI: [0.117, 0.402]Mixed Models Analysis
Primary

Overall Comfort

After four weeks of wear, subjects responded to a phone survey question regarding overall comfort of the study contact lenses (lotrafilcon B)using the following scale: 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.

Time frame: 2 weeks and 4 weeks

Population: Analysis includes all subjects that completed the study.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Senofilcon AOverall Comfort3.534 units on a scaleStandard Error 0.111
Lotrafilcon BOverall Comfort3.436 units on a scaleStandard Error 0.118
Comparison: The alternative hypothesis is that lotrafilcon B contact lenses have a lower rating of overall comfort after 4 weeks of wear compared to after 2 weeks of wear.97.46% CI: [-0.218, 0.098]Mixed Models Analysis
Primary

Visual Acuity

Visual acuity was assessed by the investigator using the Snellen chart and converted to the logarithm of the minimum angle of resolution (logMAR). logMAR ideal is 0.0 and represents 20/20 Snellen visual acuity. logMAR values \> 0.00 indicate vision poorer than the ideal and values \<0.00 indicate vision greater than the ideal.

Time frame: 2 weeks

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Senofilcon AVisual Acuity-0.012 logMAR unitsStandard Error 0.003
Lotrafilcon BVisual Acuity-0.002 logMAR unitsStandard Error 0.003
Comparison: The alternative hypothesis is that senofilcon A contact lenses are non-inferior (less than or equal to)in visual acuity to lotrafilcon B contact lenses after two weeks of wear.97.46% CI: [-0.021, -0.01]Mixed Models Analysis
Secondary

Bulbar Redness

The investigator assessed bulbar redness using the following scale: 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe

Time frame: 2 weeks

Population: Analysis includes subjects that completed the study.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Senofilcon ABulbar Redness0.465 units on a scaleStandard Error 0.031
Lotrafilcon BBulbar Redness0.532 units on a scaleStandard Error 0.03
Comparison: The alternative hypothesis is that senofilcon A contact lenses are non-inferior in bulbar redness to lotrafilcon B contact lenses after two weeks of wear.98.2% CI: [-0.068, 0.008]Mixed Models Analysis
Secondary

Limbal Redness

The investigator assessed limbal redness using the following scale: 0=None, 1=Trace, 2=Mild, 3=Moderate, 4=Severe

Time frame: 2 weeks

Population: Analysis includes subjects that completed the study.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Senofilcon ALimbal Redness0.376 units on a scaleStandard Error 0.031
Lotrafilcon BLimbal Redness0.499 units on a scaleStandard Error 0.03
Comparison: The alternative hypothesis is that senofilcon A contact lenses are non-inferior in limbal redness 5 to lotrafilcon B contact lenses after two weeks of wear.98.2% CI: [-0.123, -0.051]Mixed Models Analysis
Secondary

Symptoms of Dryness

Subjects responded to a phone survey question regarding the frequency of the sensation of dryness while wearing the study contact lenses using the following scale: 1=Extreme, 2=Moderate, 3=Slight, 4=None

Time frame: 2 weeks

Population: Analysis includes subjects that completed the study.

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Senofilcon ASymptoms of Dryness2.003 units on a scaleStandard Error 0.087
Lotrafilcon BSymptoms of Dryness2.414 units on a scaleStandard Error 0.088
Comparison: The alternative hypothesis is that senofilcon A contact lenses have less frequency of dryness than lotrafilcon B contact lenes after two weeks of wear.98.2% CI: [-0.411, -0.117]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026